Reaction

Cord Blood Transplant Therapy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 85 reports · 4 co-occurring drugs

As of the last recalculation, Cord Blood Transplant Therapy appears in 85 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 285.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Azacitidine For17285.8286.1
Fludarabine Phosphate25220.1220.3
Azacitidine18188.2188.3
Venetoclax1890.590.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.